ClinicalTrials.Veeva

Menu

Risk Behaviors in Adolescents With Chronic Diseases (Carmac)

A

Assistance Publique - Hôpitaux de Paris

Status

Enrolling

Conditions

Chronic Disease
Somatic Disorders

Treatments

Other: Questionnaire risk behaviors in adolescents with chronic diseases

Study type

Observational

Funder types

Other

Identifiers

NCT05793411
APHP210802

Details and patient eligibility

About

Little is known about the prevalence of risk behaviors (RBs), in adolescents living with a chronic condition (CC) Objectives Main objective: To characterize the engagement of adolescents with somatic CC recognized as ALD (SCC-ALD) into RBs, compared to the French GP Secondary objectives

  • To identify factors associated with RBs in adolescents with somatic CC-ALD

  • To elicit strategies of preventive action of RBs in adolescents with somatic CC-ALD Methods multicenter, cross-sectional survey , based on a mixed qualitative-quantitative approach with an explanatory sequential design (2 consecutive steps): STEP 1 : QUANTITATIVE COMPONENT

    • N expected =500
    • Inclusion criteria : 14 to 18 years, With a SCC-ALD,Without cognitive impairment and/or psychiatric disease
    • Pseudonymised self-administered paper questionnaire (50 items) completed by eligible adolescents during a visit at referring hospital
    • statistical analysis : Comparative to the French GP: matching with two datasets (Enclass-HBSC 2022 and Portraits d'Adolescents 2013 surveys); identification of risk factors and risk subgroups STEP 2 : QUALITATIVE COMPONENT: Focus groups of adolescents with somatic CC-ALD (5 focus groups of 6-8 adolescents, conducted by a researcher in SHS) Perspectives

CARMAC will :

  • Provide a better understanding of RBs in adolescents with severe somatic CC and
  • Help develop strategies to prevent RBs to enhance the strategies of reducing the addictions to psychoactive substances and health inequalities in this population
  • Serve as a methodological model for future studies

Full description

Little is known about the prevalence of risk behaviors (RBs), in adolescents living with a chronic condition (CC) Objectives Main objective: To characterize the engagement of adolescents with somatic CC recognized as ALD (SCC-ALD) into RBs, compared to the French GP Secondary objectives

  • To identify factors associated with RBs in adolescents with somatic CC-ALD

  • To elicit strategies of preventive action of RBs in adolescents with somatic CC-ALD Methods multicenter, cross-sectional survey , based on a mixed qualitative-quantitative approach with an explanatory sequential design (2 consecutive steps) STEP 1 : QUANTITATIVE COMPONENT

    • N expected =500
    • Inclusion criteria : 14 to 18 years, With a SCC-ALD,Without cognitive impairment and/or psychiatric disease
    • Pseudonymised self-administered paper questionnaire (50 items) completed by eligible adolescents during a visit at referring hospital
    • statistical analysis : Comparative to the French GP: matching with two datasets (Enclass-HBSC 2022 and Portraits d'Adolescents 2013 surveys); identification of risk factors and risk subgroups STEP 2 : QUALITATIVE COMPONENT: Focus groups of adolescents with somatic CC-ALD (5 focus groups of 6-8 adolescents, conducted by a researcher in SHS) Perspectives

CARMAC will :

  • Provide a better understanding of RBs in adolescents with severe somatic CC and
  • Help develop strategies to prevent RBs to enhance the strategies of reducing the addictions to psychoactive substances and health inequalities in this population
  • Serve as a methodological model for future studies

Enrollment

500 estimated patients

Sex

All

Ages

14 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 14 to 18 years, living with a somatic chronic condition, recognized as an ALD (long duration disease)

Exclusion criteria

  • cognitive impairment and/or psychiatric disease

Trial contacts and locations

1

Loading...

Central trial contact

Helene MELLERIO, MD; Paul JACQUIN, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems